5
Views
69
CrossRef citations to date
0
Altmetric
Research Article

Stimulation of Proliferation of a Human Osteosarcoma Cell Line by Exogenous Acidic Fibroblast Growth Factor Requires both Activation of Receptor Tyrosine Kinase and Growth Factor Internalization

, , , , &
Pages 270-280 | Received 23 Mar 1995, Accepted 19 Oct 1995, Published online: 29 Mar 2023

REFERENCES

  • Amaya, E., T. J. Musci, and M. W. Kirschner. 1991. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell 66:257–270.
  • Baldin, V., A.-M. Roman, I. Bosc-Bierne, F. Amalric, and G. Bouche. 1990. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J. 9:1511–1517.
  • Basilico, C, and D. Moscatelli. 1992. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59:115–165.
  • Birnboim, H. C., 1988. Rapid extraction of high molecular weight RNA from cultured cells and granulocytes for Northern analysis. Nucleic Acids Res. 16:1487–1497.
  • Bouche, G., N. Gas, H. Prats, V. Baldin, J.-P. Tauber, J. Teissie, and F. Amalric. 1987. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition. Proc. Natl. Acad. Sci. USA 84:6770–6774.
  • Boyer, B., and J. P. Thiery. 1993. Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line. J. Cell. Biol. 120:767–776.
  • Brogi, E., J. A. Winkles, R. Underwood, S. K. Clinton, G. F. Alberts, and P. Libby. 1993. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J. Clin. Invest. 92:2408–2414.
  • Bugler, B., F. Amalric, and H. Prats. 1991. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell. Biol. 11:573–577.
  • Burgess, W. H., and T. Maciag. 1989. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:575–606.
  • Cao, Y., M. Ekström, and R. F. Petterson. 1993. Characterization of the nuclear translocation of acidic fibroblast growth factor. J. Cell. Sci. 104:77–87.
  • Chellaiah, A. T., D. G. McEwen, S. Werner, J. Xu, and D. M. Ornitz. 1994. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/ FGF1. J. Biol. Chem. 269:11620–11627.
  • Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991–1995.
  • Cuevas, P., F. Carceller, S. Ortega, M. Zazo, I. Nieto, and G. Gimenez-Gallego. 1991. Hypotensive activity of fibroblast growth factor. Science 254: 1208–1210.
  • Curran, T., G. Peters, C. Van Beveren, N. M. Teich, and I. M. Verma. 1982. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J. Virol. 44:674–682.
  • Falnes, P.Ø., S. Choe, I. H. Madshus, B. Wilson, and S. Olsnes. 1994. Inhibition of membrane translocation of diphtheria toxin A-fragment by internal disulfide bridges. J. Biol. Chem. 269:8402–8407.
  • Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6–13.
  • Folkman, J. Y., and Y. Shing. 1992. Angiogenesis. J. Biol. Chem. 267:10931–10934.
  • Fraker, P. J., and J. C. Speck, Jr. 1978. Protein and cell membrane iodination with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-dephenylglycouril. Biochem. Biophys. Res. Commun. 80:849–857.
  • Friesel, R. E., and T. Maciag. 1995. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9:919–926.
  • Gao, G., and M. Goldfarb. 1995. Heparin can activate a receptor tyrosine kinase. EMBO J. 14:2183–2190.
  • Hammond, R. A., J. K. McClung, and M. R. Miller. 1990. Effect of DNA polymerase inhibitors on DNA repair in intact and permeable human fibroblasts: evidence that DNA polymerases δ and β are involved in DNA repair synthesis induced by N-methyl-N’-nitro-N-nitrosoguanidine. Biochemistry 29:286–291.
  • Hou, J., M. Kan, K. McKeehan, G. McBride, P. Adams, and W. L. McKeehan. 1991. Fibroblast growth factor receptors from liver vary in three structural domains. Science 251:665–668.
  • Imamura, T., K. Engleka, X. Zhan, Y. Tokita, R. Forough, D. Roeder, A. Jackson, J. A. M. Maier, T. Hla, and T. Maciag. 1990. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 249:1567–1570.
  • Jaye, M., R. Howk, W. Burgess, G. A. Ricca, I.-M. Chiu, M. W. Ravera, S. O’Brien, W. S. Modi, T. Maciag, and W. N. Drohan. 1986. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science 233:541–545.
  • Jaye, M., R. M. Lyall, R. Mudd, J. Schlessinger, and N. Sarver. 1988. Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells. EMBO J. 7:963–969.
  • Johnson, D. E., and L. T. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family of growth factors and oncogenes. Adv. Cancer Res. 60:1–41.
  • Jouanneau, J., J. Gavrilovic, D. Caruelle, M. Jaye, G. Moens, J.-P. Caruelle, and J.-P. Thiery. 1991. Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci. USA 88: 2893–2897.
  • Kashles, O., Y. Yarden, R. Fischer, A. Ullrich, and J. Schlessinger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11:1454–1463.
  • Kiefer, P., and C. Dickson. 1995. Nucleolar association of fibroblast growth factor 3 via specific sequence motifs has inhibitory effects on cell growth. Mol. Cell. Biol. 15:4364–4374.
  • Kimura, H. 1994.. Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc. Natl. Acad. Sci. USA 90:2165–2169.
  • Laemmli, U. K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680–685.
  • Li, Y., C. Basilico, and A. Mansukhani. 1994. Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. Mol. Cell. Biol. 14:7660–7669.
  • McGill, S., H. Stenmark, K. Sandvig, and S. Olsnes. 1989. Membrane interactions of diphtheria toxin analyzed using in vitro synthesized mutants. EMBO J. 8:2843–2848.
  • McLeskey, S. W., I. Y. F. Ding, M. E. Lippman, and F. G. Kern. 1994. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res. 54:523–530.
  • Mignatti, P., T. Morimoto, and D. B. Rifkin. 1992. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell. Physiol. 151:81–93.
  • Moroianu, J., and J. F. Riordan. 1994. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc. Natl. Acad. Sci. USA 90:1677–1681.
  • Moskaug, J.Ø., K. Sandvig, and S. Olsnes. 1988. Low pH-induced release of diphtheria toxin fragment A in Vero cells. J. Biol. Chem. 263:2518–2525.
  • Muesch, A., E. Hartmann, K. Rohde, A. Rubartelli, R. Sitia, and T. A. Rapoport. 1990. A novel pathway for secretory proteins? Trends Biochem. Sci. 15:86–88.
  • Nabel, E. G., Z.-Y. Yang, G. Plautz, R. Forough, X. Zhan, C. C. Haudens-child, T. Maciag, and G. J. Nabel. 1993. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature (London) 362:844–846.
  • Neufeld, G., R. Mitchell, P. Ponte, and D. Gospodarowicz. 1988. Expression of human fibroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomous cell growth. J. Cell. Biol. 106:1385–1394.
  • Nurcombe, V., M. D. Ford, J. A. Wildschut, and P. F. Bartlett. 1993. Developmental regulation of neuronal response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103–106.
  • Olsnes, S., J. Ø. Moskaug, H. Stenmark, and K. Sandvig. 1988. Diphtheria toxin entry: protein translocation in the reverse direction. Trends Biochem. Sci. 13:348–351.
  • Olsnes, S., and K. Sandvig. 1988. How protein toxins enter and kill cells, p. 39–73. In A. E. Frankel (ed.), Immunotoxins. Martinus Nijhoff Publishing, Boston.
  • Olwin, B. B., and A. Rapraeger. 1992. Repression of myogenic differentiation by aFGF, bFGF and K-FGF is dependent on cellular heparan sulfate. J. Cell. Biol. 118:631–639.
  • Pappenheimer, A. M., Jr. 1977. Diphtheria toxin. Annu. Rev. Biochem. 46:69–94.
  • Partanen, J., T. P. Makela, E. Eerola, J. Korhonen, J. Hirvonen, L. Claesson-Welsh, and K. Alitalo. 1991. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10:1347–1354.
  • Ron, D., R. Reich, M. Chedid, C. Lengel, O. E. Cohen, A. M.-L. Chan, G. Neufeld, T. Miki, and S. R. Tronick. 1993. Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. J. Biol. Chem. 268:5388–5394.
  • Ruta, M., W. Burgess, D. Givol, J. Epstein, N. Neiger, J. Kaplow, G. Crumley, C. Dionne, M. Jaye, and J. Schlessinger. 1989. Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc. Natl. Acad. Sci. USA 86:8722–8726.
  • Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  • Sano, H., R. M. Forough, A. J. Maier, J. P. Case, A. Jackson, K. Engleka, T. Maciag, and L. R. J. Wilder. 1990. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J. Cell. Biol. 110:1417–1426.
  • Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51:660–672.
  • Shaoul, E., R. Reich-Slotky, B. Berman, and D. Ron. 1995. Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene 10:1553–1561.
  • Smith, P. J., and M. C. Paterson. 1983. Effect of aphidicolin on de novo DNA synthesis, DNA repair and cytotoxicity in γ-irradiated human fibroblasts. Implications for the enhanced radiosensitivity in ataxia teleangiectasia. Biochim. Biophys. Acta 739:17–26.
  • Solari, R., N. Smithers, N. Kennard, K. Ray, and S. Grenfell. 1994. Receptor mediated endocytosis and intracellular fate of interleukin 1. Biochem. Pharmacol. 47:93–101.
  • Stachowiak, M. K., J. Moffett, A. Joy, E. Puchacz, R. Florkiewicz, and E. K. Stachowiak. 1994. Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J. Cell. Biol. 127: 203–223.
  • Stenmark, H., B. N. Afanasiev, S. A. Ariansen, and S. Olsnes. 1992. Association between diphtheria toxin A- and B-fragment and their fusion proteins. Biochem. J. 281:619–625.
  • Sundan, A., S. Olsnes, K. Sandvig, and A. Pihl. 1982. Preparation and properties of chimaeric toxins prepared from the constituent polypeptides of diphtheria toxin and ricin. Evidence for the entry of ricin A-chain via the diphtheria toxin pathway. J. Biol. Chem. 257:9733–9739.
  • Tamm, I., T. Kikuchi, and A. Zychlinsky. 1991. Acidic and basic fibroblast growth factors are survival factors with distinctive activity in quiescent BALB/c3T3 murine fibroblasts. Proc. Natl. Acad. Sci. USA 88:3372–3376.
  • Vainikka, S., V. Joukov, S. Wennström, M. Bergman, P. G. Pelicci, and K. Alitalo. 1994. Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J. Biol. Chem. 269:18320–18326.
  • Vainikka, S., J. Partanen, P. Bellosta, F. Coulier, C. Basilico, M. Jaye, and K. Alitalo. 1992. Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO J. 11: 4273–4280.
  • Wang, J.-K., G. Gao, and M. Goldfarb. 1994. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol. 14:181–188.
  • Więdłocha, A., P. Ø. Falnes, I. H. Madshus, K. Sandvig, and S. Olsnes. 1994. Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 76:1039–1051.
  • Więdłocha, A., I. H. Madshus, H. Mach, C. R. Middaugh, and S. Olsnes. 1992. Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector. EMBO J. 11:4835–4842.
  • Xu, J., M. Nakahara, J. W. Crabb, E. Shi, Y. Matuo, M. Fraser, M. Kan, J. Hou, and W. L. McKeehan. 1992. Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms. J. Biol. Chem. 267:17792–17803.
  • Yan, G., Y. Fukabori, G. McBride, S. Nikolaropolous, and W. L. McKeehan. 1993. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol. 13:4513–4522.
  • Yanagisawa-Miwa, A., Y. Uchida, F. Nakamura, T. Tomaru, H. Kido, T. Kamijo, T. Sugimoto, K. Kaji, M. Utsuyama, C. Kurashima, and H. Ito. 1992. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401–1403.
  • Yu, Y.-L., H. Kha, J. A. Golden, A. A. J. Migchielsen, E. J. Goetzl, and C. W. Turck. 1992. An acidic fibroblast growth factor protein generated by alternate splicing acts like an antagonist. J. Exp. Med. 175:1073–1080.
  • Zhan, X., X. Hu, S. Friedman, and T. Maciag. 1992. Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH 3T3 cells. Biochem. Biophys. Res. Commun. 188:982–991.
  • Zhan, X., X. Hu, R. Friesel, and T. Maciag. 1993. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. J. Biol. Chem. 268:9611–9620.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.